Acolbifene () (developmental code names EM-652, SCH-57068) is a
nonsteroidal A nonsteroidal compound is a drug that is not a steroid nor a steroid derivative. Nonsteroidal anti-inflammatory drugs (NSAIDs) are distinguished from corticosteroids as a class of anti-inflammatory agents.
List of nonsteroidal steroid receptor mo ...
selective estrogen receptor modulator
Selective estrogen receptor modulators (SERMs), also known as estrogen receptor agonists/antagonists (ERAAs), are a class of drugs that act on estrogen receptors (ERs). Compared to pure ER agonists–antagonists (e.g., full agonists and silent ...
(SERM) which, as of 2015, is in
phase III clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human subject research, human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel v ...
s for the treatment of
breast cancer
Breast cancer is a cancer that develops from breast tissue. Signs of breast cancer may include a Breast lump, lump in the breast, a change in breast shape, dimpling of the skin, Milk-rejection sign, milk rejection, fluid coming from the nipp ...
.
See also
*
Acolbifene/prasterone
*
List of investigational sex-hormonal agents § Estrogenics
References
External links
Acolbifene - AdisInsight
Benzopyrans
Hormonal antineoplastic drugs
4-Hydroxyphenyl compounds
1-Piperidinyl compounds
Selective estrogen receptor modulators
Hydroxyarenes
{{antineoplastic-drug-stub